The German chemical sector, a cornerstone of the nation’s industrial identity, is currently gripped by a high-stakes corporate power struggle. At the center of this storm is Evonik Industries, the specialty chemicals giant, which has found itself the target of an increasingly aggressive takeover bid from industry behemoth BASF. What began as a series of private negotiations has escalated into a public spectacle of speculation, involving institutional giants, powerful labor unions, and a complex web of overlapping interests that have left market analysts scrambling for clarity.
The Trigger: A Misunderstood Remark
The chaos erupted on a Friday morning, when the leadership at Evonik’s Düsseldorf headquarters began receiving an influx of frantic inquiries. Institutional investors and market analysts, clearly spooked by rumors, were demanding to know if the company was facing an existential liquidity crisis. The catalyst for this panic was a comment regarding "financing issues" attributed to Michael Vassiliadis, the head of the IG BCE chemical union and a deeply influential figure in the German corporate landscape.
Evonik acted swiftly to quell the rumors, issuing a categorical denial regarding any limitations to its financial strength or access to capital markets. However, the damage to market sentiment necessitated a direct clarification from Vassiliadis himself. In an interview with the Handelsblatt, Vassiliadis sought to contextualize his earlier remarks, explaining that his concerns were not about Evonik’s operational solvency, but rather about the structural limitations of its primary shareholder, the RAG-Stiftung.
According to Vassiliadis, the RAG-Stiftung relies heavily on dividends from Evonik to fulfill its statutory obligations. Consequently, the foundation is unable to provide the capital injection necessary for Evonik’s long-term growth and strategic expansion. The clarification served to soothe markets, but it also underscored the precarious nature of the ownership structure currently surrounding Evonik.
Chronology of an Escalating Takeover
The drama surrounding Evonik did not emerge in a vacuum. It is the result of a calculated, multi-stage attempt by BASF to consolidate its position within the German chemical landscape.
- Late September: The initial overture. BASF officially presented an offer to acquire Evonik, valuing the company at approximately €10.3 billion, which equated to €22.15 per share.
- The Rejection: Evonik’s management board, citing an undervaluation of the firm’s future growth potential and market positioning, promptly rejected the offer, labeling it insufficient.
- The Escalation: As the weeks progressed, pressure mounted. BASF, clearly unwilling to walk away, returned to the negotiating table.
- The New Bid: By late October, reports from industry insiders confirmed that BASF had sweetened the deal, raising its offer to €24 per share. This adjustment pushes the total valuation of the potential acquisition beyond the €11 billion mark, forcing the RAG-Stiftung—which holds roughly 44% of Evonik’s shares—to confront a difficult strategic decision.
The RAG-Stiftung: A Foundation at a Crossroads
The RAG-Stiftung is not a typical shareholder. Created to manage the long-term financial liabilities resulting from the end of coal mining in Germany, its mandate is focused on stability and social responsibility. This creates a fundamental tension: does the foundation maximize its immediate return by selling its stake to BASF at a premium, or does it maintain its holding in the hopes that Evonik can deliver higher long-term value under its current management?
Vassiliadis’s involvement is critical here. As the deputy chairman of the RAG-Stiftung’s board of trustees, his perspective carries significant weight. His public acknowledgment that the foundation is essentially "dividend-dependent" signals that the status quo may be unsustainable. If the foundation cannot participate in capital increases, it may find itself being slowly diluted or forced into a sale to ensure the liquidity required for its primary mission—the environmental and social legacy of German coal mining.
The Vassiliadis Factor: A Man in Two Worlds
Michael Vassiliadis occupies a unique and powerful position in the German economy. His influence is not limited to his role in the union or the RAG-Stiftung; he has served on the BASF supervisory board for over two decades. Furthermore, he sat on the Evonik supervisory board from 2012 to 2016.
This "triple-hat" dynamic makes him the most significant individual player in the takeover battle. Critics and observers alike are asking: How much of this conflict is driven by genuine industrial strategy, and how much is being shaped by the complex, long-standing relationships within the German corporate establishment?
Vassiliadis effectively sits in two worlds. He represents the interests of the workers at both the predator (BASF) and the target (Evonik), while also overseeing the financial health of the RAG-Stiftung. This duality allows him to influence the narrative in ways that few others can. While other stakeholders remain tight-lipped, preferring the discretion of boardrooms, Vassiliadis has become the de facto mediator—and, arguably, the gatekeeper—of the entire process.
Implications for the German Chemical Sector
The potential merger of BASF and Evonik represents more than just a corporate acquisition; it signals a potential fundamental restructuring of the German chemical industry.
1. Market Concentration and Competition
If the merger proceeds, the resulting entity would possess an unprecedented level of dominance in the specialty chemicals market. Antitrust regulators in Brussels and Berlin will undoubtedly subject any such deal to intense scrutiny. The concern is that a consolidation of this magnitude could stifle innovation and reduce the bargaining power of downstream customers.
2. The Future of Labor Relations
For IG BCE, the stakes are existential. Any merger of this scale invariably leads to "synergies"—a corporate euphemism for layoffs and site closures. Vassiliadis’s ability to protect jobs while facilitating a major industrial transition will be the ultimate test of his leadership. If he is seen as facilitating a deal that leads to mass redundancies, his position within the union could become untenable.
3. Industrial Policy in the Green Transition
The chemical industry is currently facing the massive, capital-intensive challenge of decarbonization. Some industry proponents argue that consolidation is necessary to create "national champions" that have the scale to invest in green technologies and remain competitive against global rivals in China and the United States. From this perspective, the BASF-Evonik deal is not just about profit; it is about the long-term survival of German industrial manufacturing in a carbon-neutral world.
Conclusion: The Waiting Game
As it stands, the ball is firmly in the court of the RAG-Stiftung. The foundation must weigh the immediate financial windfall of a €24-per-share sale against the long-term uncertainty of holding onto a stake in a company that is struggling to fund its own growth.
Meanwhile, the industry watches the movements of Michael Vassiliadis with bated breath. His ability to navigate the conflicting demands of his various roles will likely determine the outcome of this struggle. Will he push for a consolidation that secures the long-term viability of the German chemical sector, or will he advocate for the independence of Evonik, even at the cost of its future growth potential?
For now, the rumors have been silenced, the financing questions answered, and the official offers placed on the table. But the silence is deceptive. In the high-stakes world of German chemicals, the battle for Evonik is only just beginning, and the final decision will resonate far beyond the boardroom, touching the lives of thousands of workers and shaping the future of Germany’s industrial heartland.
